Zhejiang Medicine Co Ltd
SSE:600216
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Medicine Co Ltd
SSE:600216
|
CN |
|
R
|
ResGen Ltd
BSE:543805
|
IN |
|
Green Cross Holdings
KRX:005250
|
KR |
|
S
|
SMC Global Securities Ltd
NSE:SMCGLOBAL
|
IN |
|
C
|
Cognizant Technology Solutions Corp
SWB:COZ
|
US |
|
Highpeak Energy Inc
NASDAQ:HPK
|
US |
|
Loomis AB
STO:LOOMIS
|
SE |
Relative Value
The Relative Value of one
Zhejiang Medicine Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 15.2 CNY,
Zhejiang Medicine Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Zhejiang Medicine Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Zhejiang Medicine Co Ltd
SSE:600216
|
14.6B CNY | 1.6 | 11.7 | 9.8 | 9.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.2 | 41.8 | 28.3 | 30.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.4 | 15.6 | 9.7 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.6 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |